If you are a hospital dealing with a shortage of surgeons skilled in complex reconstructive surgery — this project developed the MUSA-3 robot that reduces the time needed to obtain expert skills and standardizes high-quality outcomes.
Scaling Production of the World's First Robotic System for High-Precision Microsurgery
Imagine trying to sew a piece of thread thinner than a human hair; it's incredibly difficult and takes years to master. This technology acts like a high-tech steady-hand for surgeons, filtering out shakes and making tiny movements much easier. It allows doctors to perform complex repairs on tiny blood vessels and nerves with superhuman precision.
What needed solving
Complex microsurgery requires years of specialized training and results in variable patient outcomes due to the extreme precision needed for structures under 1 mm.
What was built
The MUSA-3 microsurgical robot, featuring improved hardware, software, and a design optimized for usability and mass production.
Who needs this
Who can put this to work
If you are a manufacturer dealing with rigid robotic systems that don't fit existing tools — this project developed a robot with a gripper mechanism that enables the use of existing microsurgical instruments.
If you are a teaching facility dealing with the fact that it takes years of training to acquire precise motor skills — this project developed robotic assistance that lowers the barrier to performing complex anastomosis.
Quick answers
What is the cost or pricing model for the MUSA system?
Based on available project data, specific pricing is not disclosed, but the objective states the robot is designed to be highly efficient to reduce costs for health providers.
How is the industrial scale of production being handled?
The project specifically focuses on upscaling and optimizing manufacturability to allow for rapid market uptake and the introduction of the MUSA-3 model.
What is the IP and licensing status of the technology?
Based on available project data, the technology originated from a collaboration between Maastricht University Medical Center and Technical University Eindhoven, with Microsure BV acting as the spin-off company.
What is the regulatory status of the product?
The MUSA system is described as the world's first clinically available CE-certified microsurgical robot.
What is the timeline for market expansion?
MicroSure intends to introduce MUSA in all parts of Europe before 2029.
Who built it
The project is led by a single partner, Microsure BV, a Dutch SME. This 100% industry-led consortium indicates a transition from academic research (originating from TU/e and MUMC+) to a purely commercial execution phase focused on manufacturing and market rollout.
Contact Microsure BV in the Netherlands
Talk to the team behind this work.
Contact us to find distribution partners for robotic surgical systems in Europe.